Mycophenolate sodium 99%

RPG Life Sciences offers a range of high value synthetic APIs in the general therapeutic category. With presence in Europe, Latin America and Asia, RPGLS is making forays into the US markets. With a strong focus on R&D, the API business is building a robust product pipeline to enable new product launches consistently. Our growing product portfolio having US & EU DMFs in eCTD Formats cover following therapeutic categories:

• Immunosuppressants
• Anti-psychotic, Anti-anginal,
• Anthelmentics, Anti-convulsant, Anti-spasmodic etc.